Search results for " growth" in Articles / App Notes
Article
Impurity Testing of Biologic Drug Products
Dinwoodie adds that the materials used in the production process to support cell growth, extract, and purify the therapeutic protein must be removed from the final dosage form. “Residual amounts of th…
Article
Generating a Fully Processed Antibody
…evels to fully process all the biopharmaceutical at high titers without interfering with normal cell growth and the secretion of the molecule. Finally, some multispecific antibody platforms require t…
Article
A Bright Future for the Plasma Fractionation Industry
Ajmani explained that the rapid economic growth in several Asian countries has led to an increased focus on critical care and rare genetic disorders, where plasma protein therapeutics find a majority …
Article
The Challenge of Disruptive Technologies in Bioprocessing
…iopharmaceuticals and the growing R&D expenditure in biopharma companies are factors driving the growth of the global biomanufacturing industry, including downstream bioprocessing,” adds Orjana Terov…
Article
Contract Manufacturing Through the Years
…armaceutical Technology has served the bio/pharmaceutical industry have been years of momentous growth and change in the way drugs are discovered, developed, manufactured, and sold. Contract developm…
Article
Biopharma in 2016: Higher Quality Drugs, Less Expensive Manufacturing
The global biopharmaceuticals market was valued at $162 billion in 2014 and pre¬dicted by Persistence Market Research to grow at a compound annual growth rate of 9.4% from 2014 to 2020 to reach $278 b…
Article
Innovation vs. Capacity: How CMOs Compete
Those strategies are important because individual CMOs cannot depend on general organic market growth alone to propel their own revenue and profitability growth. Having well-thought-out strategies tha…
Article
A Platform Approach for the Identity Testing of Multi-Component Cell-Culture Media
Cell-culture media are composed of essential raw materials that are required for cell growth and expression. Similar cell-culture media may be used simultaneously in one or few biological processes at…
Article
Monoclonal Antibodies Key to Unlocking the Biosimilars Market
This growth in large part is due to the fact that numerous monoclonal antibody (mAb) biosimilars are expected to be launched in the next few years as patents on key drugs, such as infliximab (Remicade…
Article
Drugs, At What Cost?
Annual growth in spending levels will reach a low point in 2013, the report says, but will rebound from negative $3 billion in 2012 to $20-25 billion by 2017. In emerging markets (more than 20 nations…